Papilledema epidemiology and demographics: Difference between revisions

	Papilledema
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Papilledema from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Papilledema epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Papilledema epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Papilledema epidemiology and demographics
CDC on Papilledema epidemiology and demographics
Papilledema epidemiology and demographics in the news
Blogs on Papilledema epidemiology and demographics
Directions to Hospitals Treating Papilledema
Risk calculators and risk factors for Papilledema epidemiology and demographics

Revision as of 00:15, 19 July 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:Kalsang Dolma, MBBS

Papilledema occurs in approximately 50% of patients with a brain tumour.

@@ Line 5: / Line 5: @@
 ==Epidemiology and Demographics==
+Papilledema occurs in approximately 50% of patients with a [[brain tumour]].
-Papilledema occurs in approximately 50% of those with a [[brain tumour]].